Many states are grappling with the appropriate prescription of controlled substances, using an array of different regulatory strategies, overseen by different agencies. This report gathers in one place the numerous state regulations affecting prescription drugs in all 50 states, including workers with injuries. The report also provides information on some of the most prominent prescription drug issues stakeholders are concerned about in 2023, such as the following:

• Workers’ compensation drug formularies
• Rules for limiting and monitoring opioid prescriptions
• Price regulations for pharmacy- and physician-dispensed drugs
• Expanded role for pharmacists in patient care
• Prescription drug monitoring programs
• Pharmacy benefit manager regulations
• Medical marijuana regulations

The tables in this report were compiled from completed surveys of two agencies for each of the 50 states and the District of Columbia. Since prescription drug regulations are changing rapidly in the United States, the information in this report is a snapshot in time, as of January 1, 2023.

Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2023. Karen Rothkin. April 2023. WC-23-27.

Video:

Copyright: WCRI